ライフサイエンスコーパス: nocardiosis

1 stic regression to identify risk factors for nocardiosis.

2 oxazole prophylaxis was not found to prevent nocardiosis.

3 a psoas abscess due to spread from pulmonary nocardiosis.

4 of the common taxa associated with clinical nocardiosis.

5 PA), seven with mucormycosis, and three with nocardiosis.

6 ong the 30 cases with central nervous system nocardiosis, 13 (43.3%) had no neurological symptoms.

7 ortality was 10-fold higher in patients with nocardiosis (16.2%, 19/117) than in control transplant r

8 Several Nocardia strains associated with nocardiosis, a potentially life-threatening disease, hou

9 n transplant (SOT) recipients are at risk of nocardiosis, a rare opportunistic bacterial infection, b

10 ntrol study of adult patients diagnosed with nocardiosis after SOT between 2000 and 2014 in 36 Europe

11 We identified 5 risk factors for nocardiosis after SOT.

12 h mortality in 33 patients with disseminated nocardiosis, although survivors had a higher rate of lin

13 One hundred and seventeen cases of nocardiosis and 234 control patients were included.

14 ed computed tomography features of pulmonary nocardiosis and compared immunocompetent and immunocompr

15 ctors associated with 1-year mortality after nocardiosis and describe the outcome of patients receivi

16 om patients with disseminated/extrapulmonary nocardiosis and healthy controls was screened for anticy

17 patients studied with central nervous system nocardiosis and in no healthy controls (n = 14).

18 areas of uncertainty in our understanding of nocardiosis and propose a general approach to nocardiosi

19 s work has shown that Module 5 of the NOCAP (nocardiosis associated polyketide) synthase iterates pre

20 very and structure elucidation of the NOCAP (nocardiosis-associated polyketide) aglycone by first ful

21 polyketide synthase designated as the NOCAP (NOCardiosis-Associated Polyketide) synthase, whose produ

22 All three nocardiosis cases were detected by PCR and culture.

23 We report a case of pulmonary nocardiosis caused by Nocardia thailandica in a 66-year-

24 study that included 117 SOT recipients with nocardiosis diagnosed between 2000 and 2014.

25 We identified 81 nocardiosis episodes in 74 allo- and 7 auto-HCT recipien

26 s retrospective international study reviewed nocardiosis episodes in HCT recipients and described the

27 We evaluated a cohort of SOT recipients with nocardiosis for associations with 12-month mortality.

28 recipients diagnosed with culture-confirmed nocardiosis from 2000 to 2020.

29 wever, these features are more suggestive of nocardiosis in the setting of an underling immunocomprom

30 fter SOT and to describe the presentation of nocardiosis in these patients.

31 factors have been identified for developing nocardiosis in this population, little is known regardin

32 Nocardiosis is a late post-HCT infection usually manifes

33 Nocardiosis is a rare, life-threatening opportunistic in

34 Nocardiosis is an uncommon yet potentially devastating i

35 Survival from murine pulmonary nocardiosis is highly dependent on CXC chemokine recepto

36 Incidence of nocardiosis is likely to increase as well, and it is vit

37 Nocardiosis is rare after hematopoietic cell transplanta

38 independently associated with development of nocardiosis; low-dose cotrimoxazole prophylaxis was not

39 Nocardiosis occurred a median of 8 (IQR: 4-18) months po

40 Nocardiosis occurred at a median of 17.5 (range, 2-244)

41 Pulmonary nocardiosis presents mainly as multiple pulmonary nodule

42 Nocardiosis primarily occurs in the setting of immunocom

43 age of 39.5 years; 76% male) with pulmonary nocardiosis proved by bronchoalveolar lavage or biopsy w

44 g should be performed in HCT recipients with nocardiosis regardless of neurological symptoms.

45 lity was 10-fold higher in SOT patients with nocardiosis than in those without.

46 ocardiosis and propose a general approach to nocardiosis therapy, accounting for response and toleran

47 Acute rejection in the year before nocardiosis was associated with improved survival (OR, 0

48 Pulmonary nocardiosis was defined by a combination of clinical, ra

49 group analysis of patients with disseminated nocardiosis was performed to analyze treatment variables

50 One hundred twenty-seven patients with nocardiosis were randomly selected from 5 provinces of I

51 on rather than severity and/or management of nocardiosis, were independently associated with 1-year m

52 eroides accounts for most transplant-related nocardiosis, while Nocardia brasiliensis rarely causes i